Blood: 129 (1)

EDITORIAL

You have access
Introduction to a review series on chronic GVHD: from pathogenic B-cell receptor signaling to novel therapeutic targets
Robert Zeiser and Robert S. Negrin

Blood 2017 129:1-2; doi: https://doi.org/10.1182/blood-2016-10-735696

INSIDE BLOOD COMMENTARIES

Clinical Trials and Observations

You have access
Antecedent CHIP in CML?
Matthew J. Walter

Blood 2017 129:3-4; doi: https://doi.org/10.1182/blood-2016-11-746842
Hematopoiesis and Stem Cells

You have access
HSCs: they can’t live without their SINs
Vincent van den Boom

Blood 2017 129:4-5; doi: https://doi.org/10.1182/blood-2016-11-750521
Lymphoid Neoplasia

You have access
Exposing Hodgkin-Reed-Sternberg cells
Christian Steidl

Blood 2017 129:6-7; doi: https://doi.org/10.1182/blood-2016-11-746701
Lymphoid Neoplasia

You have access
Flow in a fibril-forming disease
Stefan Schönland and Ute Hegenbart

Blood 2017 129:7-8; doi: https://doi.org/10.1182/blood-2016-11-746693
Lymphoid Neoplasia

You have access
Targeting CD19: the good, the bad, and CD81
Mireya Paulina Velasquez and Stephen Gottschalk

Blood 2017 129:9-10; doi: https://doi.org/10.1182/blood-2016-11-749143
Thrombosis and Hemostasis

You have access
Correcting the hemophilic imbalance
David A. Lane

Blood 2017 129:10-11; doi: https://doi.org/10.1182/blood-2016-11-748822

REVIEW SERIES

Chronic Graft-versus-Host Disease

You have access
Chronic graft-versus-host disease: biological insights from preclinical and clinical studies
Kelli P. A. MacDonald, Geoffrey R. Hill and Bruce R. Blazar

Blood 2017 129:13-21; doi: https://doi.org/10.1182/blood-2016-06-686618
Chronic Graft-versus-Host Disease

You have access
Mechanistic approaches for the prevention and treatment of chronic GVHD
Corey S. Cutler, John Koreth and Jerome Ritz

Blood 2017 129:22-29; doi: https://doi.org/10.1182/blood-2016-08-686659
Chronic Graft-versus-Host Disease

You have access
Classification systems for chronic graft-versus-host disease
Stephanie J. Lee

Blood 2017 129:30-37; doi: https://doi.org/10.1182/blood-2016-07-686642

CLINICAL TRIALS AND OBSERVATIONS

You have access
Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy
TaeHyung Kim, Marc S. Tyndel, Hyeoung Joon Kim, Jae-Sook Ahn, Seung Hyun Choi, Hee Jeong Park, Yeo-kyeoung Kim, Soo Young Kim, Jeffrey H. Lipton, Zhaolei Zhang and Dennis (Dong Hwan) Kim

Blood 2017 129:38-47; doi: https://doi.org/10.1182/blood-2016-04-708560

HEMATOPOIESIS AND STEM CELLS

You have access
Histone acetyltransferase activity of MOF is required for adult but not early fetal hematopoiesis in mice
Daria G. Valerio, Haiming Xu, Meghan E. Eisold, Carolien M. Woolthuis, Tej K. Pandita and Scott A. Armstrong

Blood 2017 129:48-59; doi: https://doi.org/10.1182/blood-2016-05-714568
You have access
The chromatin-associated Sin3B protein is required for hematopoietic stem cell functions in mice
David J. Cantor and Gregory David

Blood 2017 129:60-70; doi: https://doi.org/10.1182/blood-2016-06-721746

LYMPHOID NEOPLASIA

You have access
Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma
Jing Du, Martin Neuenschwander, Yong Yu, J. Henry M. Däbritz, Nina-Rosa Neuendorff, Kolja Schleich, Aitomi Bittner, Maja Milanovic, Gregor Beuster, Silke Radetzki, Edgar Specker, Maurice Reimann, Frank Rosenbauer, Stephan Mathas, Philipp Lohneis, Michael Hummel, Bernd Dörken, Jens Peter von Kries, Soyoung Lee and Clemens A. Schmitt

Blood 2017 129:71-81; doi: https://doi.org/10.1182/blood-2016-02-700773
You have access
The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment
Eli Muchtar, Dragan Jevremovic, Angela Dispenzieri, David Dingli, Francis K. Buadi, Martha Q. Lacy, Wilson Gonsalves, Suzanne R. Hayman, Prashant Kapoor, Nelson Leung, Stephen Russell, John A. Lust, Yi Lin, Ronald S. Go, Rajshekhar Chakraborty, Steven Zeldenrust, Shaji K. Kumar, Robert A. Kyle, S. Vincent Rajkumar and Morie A. Gertz

Blood 2017 129:82-87; doi: https://doi.org/10.1182/blood-2016-06-721878
You have access
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies
Changchun Deng, Mark R. Lipstein, Luigi Scotto, Xavier O. Jirau Serrano, Michael A. Mangone, Shirong Li, Jeremie Vendome, Yun Hao, Xiaoming Xu, Shi-Xian Deng, Ronald B. Realubit, Nicholas P. Tatonetti, Charles Karan, Suzanne Lentzsch, David A. Fruman, Barry Honig, Donald W. Landry and Owen A. O’Connor

Blood 2017 129:88-99; doi: https://doi.org/10.1182/blood-2016-08-731240
Brief Report

You have access
Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking
Friederike Braig, Anna Brandt, Mariele Goebeler, Hans-Peter Tony, Anna-Katharina Kurze, Peter Nollau, Thomas Bumm, Sebastian Böttcher, Ralf C. Bargou and Mascha Binder

Blood 2017 129:100-104; doi: https://doi.org/10.1182/blood-2016-05-718395

THROMBOSIS AND HEMOSTASIS

You have access
Design and characterization of an APC-specific serpin for the treatment of hemophilia
Stéphanie G. I. Polderdijk, Ty E. Adams, Lacramioara Ivanciu, Rodney M. Camire, Trevor P. Baglin and James A. Huntington

Blood 2017 129:105-113; doi: https://doi.org/10.1182/blood-2016-05-718635

TRANSPLANTATION

You have access
MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults
Corinna La Rosa, Jeff Longmate, Joy Martinez, Qiao Zhou, Teodora I. Kaltcheva, Weimin Tsai, Jennifer Drake, Mary Carroll, Felix Wussow, Flavia Chiuppesi, Nicola Hardwick, Sanjeet Dadwal, Ibrahim Aldoss, Ryotaro Nakamura, John A. Zaia and Don J. Diamond

Blood 2017 129:114-125; doi: https://doi.org/10.1182/blood-2016-07-729756

LETTERS TO BLOOD

You have access
Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients
Satoshi Nishiwaki, Matsuyoshi Maeda, Masahiro Yamada, Shingo Okuno, Yasuhiko Harada, Kotaro Suzuki, Shingo Kurahashi, Fumihiro Urano, Shozo Okamura and Isamu Sugiura

Blood 2017 129:126-128; doi: https://doi.org/10.1182/blood-2016-08-734947
You have access
Comprehensive analysis of a myeloperoxidase-negative acute promyelocytic leukemia
Maël Heiblig, Etienne Paubelle, Adriana Plesa, Marie-Oldine Geay, Delphine Manzoni, Sophie Gazzo, Isabelle Tigaud, Evelyne Callet-Bauchu, Sarah Huet, Gilles Salles, Xavier Thomas, Sandrine Hayette and Pierre Sujobert

Blood 2017 129:128-131; doi: https://doi.org/10.1182/blood-2016-09-741355

BLOOD WORK

You have access
Plasma cell neoplasm with plasmablastic morphology mimicking acute leukemia
Maryam Pourabdollah and Hong Chang

Blood 2017 129:132; doi: https://doi.org/10.1182/blood-2016-09-738021
You have access
Incidental finding of 3 Southeast Asian ovalocytosis cases by attentive examination of blood smears
Pierre-Antoine Moulin and Véronique Baccini

Blood 2017 129:133; doi: https://doi.org/10.1182/blood-2016-07-729855

ERRATUM

You have access
Maxson JE, Ries RE, Wang Y-C, et al. CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML. Blood. 2016;127(24):3094-3098.
Blood 2017 129:134; doi: https://doi.org/10.1182/blood-2016-11-751834

Top Menu

Ash User

Advertisement

Table of Contents

January 05, 2017; 129 (1)

EDITORIAL

INSIDE BLOOD COMMENTARIES

REVIEW SERIES

CLINICAL TRIALS AND OBSERVATIONS

HEMATOPOIESIS AND STEM CELLS

LYMPHOID NEOPLASIA

THROMBOSIS AND HEMOSTASIS

TRANSPLANTATION

LETTERS TO BLOOD

BLOOD WORK

ERRATUM

Issue Highlights

Advertisement

American Society of Hematology

Information for:

Top Menu

Ash User

Table of Contents

January 05, 2017; 129 (1)

EDITORIAL

INSIDE BLOOD COMMENTARIES

REVIEW SERIES

CLINICAL TRIALS AND OBSERVATIONS

HEMATOPOIESIS AND STEM CELLS

LYMPHOID NEOPLASIA

THROMBOSIS AND HEMOSTASIS

TRANSPLANTATION

LETTERS TO BLOOD

BLOOD WORK

ERRATUM

Issue Highlights

Jump to

American Society of Hematology

Information for: